Public annual accounts

Pharmaphie EVG financials

Name: Pharmaphie EVG financials
Creator: Upswitch
License: https://www.upswitch.app/terms-and-conditions

A multi-period view of the public annual-account figures reported for Pharmaphie EVG, with comparable measures and links to available source documents.

Company overview

Registry number

0425476840

Fiscal coverage

2024–2025

Public sources

cbso_bulk

Data updated

Jul 28, 2026

Financial evidence

Latest movements for Pharmaphie EVG

2025 versus 2024

Operating line: €132,818
EBITDA: €40,365
Total assets: €229,312
Equity: €105,896

EBITDA margin +30.4% · Equity ratio +46.2%

Multi-year filings

Filed annual accounts by fiscal year

Public regulator-filed figures across 2 years.

Source: NBB/CBSO

Fiscal year	Gross margin	EBITDA	Total assets	Equity	Filing
202530 Sept 2025	€132,818	€40,365	€229,312	€105,896	-
202430 Sept 2024	€148,916	€60,048	€219,151	€101,440	-

Gross margin line from gross margin (abbreviated schema). This is not reported turnover, so it is not used as a public valuation base.EBITDA basis: operating profit plus full add-backs.

Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.

Public company datasets

Explore the underlying reports

Valuation

2 valuation checkpoints · 2024 to 2025 · Method family

Open report